AzTrials
AzTrials

Altered Passive Eruption of TeethNCT05478317

Esthetic Crown Lengthening With Closed Piezoelectric in Comparison to Open Flap Approach

A study testing ECL- mPZ and ECL-OF in people with Altered Passive Eruption of Teeth, run by Augusta University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In this randomized clinical trial, the investigators are comparing two different approaches for Esthetic crown lengthening- a minimally invasive approach using piezoelectric (PZ) and a traditional open flap approach (OF). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Altered Passive Eruption of Teeth
What is being tested?
ECL- mPZ and ECL-OF
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteUnited States
Study dates
18 May 2022to 18 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with a gummy smile due to APE (Type 1B) in two or more maxillary anterior teeth
  • Patients with normal muscular efficiency of the upper lip
  • Patients with no vertical skeletal defects

Who cannot join

  • Patients with systemic condition that prevent periodontal surgery
  • Patients who smoke
  • Patients with previous periodontal surgery in the same area
  • Pregnant women

Trial locations and contacts

1 site in 1 country.

Ahmed El-Awady, BDS, MS, PHD contact

706-721-5755

aelawady@augusta.edu

Jaspreet Farmaha, PHD contact

706-721-1270

jfarmaha@augusta.edu

United States1 site, 1 recruiting
  • Augusta University-Dental College of Georgia

    Augusta, Georgia, 30912

    Ahmed El-Awady, BDS, MS, PhD, 706-721-5755, aelawady@augusta.edu

    Jaspreet Farmaha, PhD, 7067211270, jfarmaha@augusta.edu

    Recruiting

Other trials in United States

About this study

In this randomized clinical trial, the investigators are comparing two different approaches for Esthetic crown lengthening- a minimally invasive approach using piezoelectric (PZ) and a traditional open flap approach (OF).

Read the detailed description

The altered passive eruption is diagnosed when there is an excessive gingival display with short clinical crowns. Esthetic crown lengthening (ECL) is the most common surgical treatment of altered passive eruption. Traditional ECL involves osseous resection with gingivectomy or apical displaced gingiva. The amount of soft and hard tissue removal in this technique aims to provide a healthy and esthetically acceptable crown height. However, gingival tissue coronal rebound is one of the most noted post-operative complications of traditionally used techniques. On the other hand, surgical techniques that include flap reflection may cause more coronal displacement of the gingival margin. Hence, it is crucial to assess different surgical techniques to determine the most effective technique that gives the required outcomes with maximum patient satisfaction.

Piezoelectric bone surgery delivers high precision in resection, good tactile sensibility, and permits a selective cut of mineralized tissue while sparing soft tissue. Further, the minimally invasive technique (mECL) was suggested to reduce pain, post-op discomfort, and procedure duration, and to accelerate the healing process. The mECL technique conveys a potential alternative approach as a sutureless, atraumatic, and less invasive technique that has been shown to increase patient satisfaction and comfort. In addition, using piezoelectric for osseous resection in this closed approach increases the favorable surgical outcomes. However, the osseous resection in mECL may be incomplete and results in a coronal rebound on the gingival contour. In addition, osseous resection in this approach is very technique sensitive to avoid root damage and uneven bone resection. A few studies and even a fewer clinical trials evaluated the clinical outcome of mECL using piezoelectric for osseous resection (PZ). Hence, in this randomized clinical trial, gingival margin and bone crest stability will be evaluated after a minimally invasive approach using piezoelectric (PZ) and a traditional open flap approach (OF).

Being tested
ECL- mPZ, ECL-OF
Keywords
Crown lengthening, Open-flap approach, Piezoelectric approach

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ECL- mPZProcedure or surgery

    Flapless Technique using Piezoelectric (PZ):

    Gingivectomy and intra-sulcular incision will be carried out to remove strip of outlined marginal gingiva. However, no flap will be reflected the osseous recontouring will be carried using special piezoelectric tip below gingival margin. The required distance between the bone crest and the gingival margin will be checked by inserting a periodontal probe into the incision below gingival margin.

  • ECL-OFProcedure or surgery

    Open Flap Technique (OF):

    Gingivectomy and intra-sulcular incision will be carried out to remove strip of outlined marginal gingiva. Full mucoperiosteal flap will be elevated to preform ostectomy and/or osteoplasty until the desired distance achieved between the bone crest and the gingival margin. After achieving the new supracrestal distance, the flap will be sutured.

Study groups in NCT05478317
Study groupRoleWhat they receive
Control group: Crown lengthening using a traditional open-flap approach (OF).Active comparatorEsthetic Crown lengthening done using a traditional open-flap approach (OF).
Receives: Procedure: ECL-OF
Test group: Crown lengthening using a minimally invasive approach by piezoelectric (PZ).ExperimentalEsthetic Crown lengthening done using a minimally invasive approach using piezoelectric (PZ).
Receives: Procedure: ECL- mPZ

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of supracrestal width (cementoenamel junction to alveolar crest CEJ-AC)

    Change of the supracrestal width will be measured using cone beam computed tomography (CBCT).

    Measured: CBCT parameter will be evaluated before the surgery and at 12 month after the surgery.

Secondary outcomes (3)
  1. Change on Probing depth (PD)

    Change on Probing depth (PD)

    Measured: PD will be evaluated prior to surgery and 6 and 12 month after surgery

  2. Change on Bleeding on probing (BOP)

    Change on Bleeding on probing (BOP)

    Measured: BOP will be evaluated prior to surgery and 6 and 12 month after surgery

  3. Change clinical attachment level (CAL).

    Change on clinical attachment level (CAL).

    Measured: CAL will be evaluated prior to surgery and 6 and 12 month after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2022
  2. Study start18 May 2022
  3. Primary completion18 Jan 2025 (estimated)
  4. Study completion18 Jan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Subjects' matching inclusion criteria will be randomly assigned to control (OF) or tested (PZ) groups. After eligibility has been ascertained and consent has been obtained, subjects planned for ECL will be enrolled in the study and assigned to the group in 1:1 ratio using computer-generated block randomization scheme.
Masking
None (open label)
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05478317
Sponsor's protocol ID
1807704
Status last verified
Jul 2022
First submitted
19 Jul 2022
Last updated
1 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing ECL- mPZ and ECL-OF in people with Altered Passive Eruption of Teeth, run by Augusta University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed El-Awady, BDS, MS, PHD (706-721-5755, aelawady@augusta.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of supracrestal width (cementoenamel junction to alveolar crest CEJ-AC) (time frame: CBCT parameter will be evaluated before the surgery and at 12 month after the surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in